Published in Gastrointest Endosc on April 01, 1987
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med (1999) 4.22
Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet (2000) 2.43
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet (1997) 2.28
Surgical aspects of gastrointestinal persimmon phytobezoar treatment. Am J Surg (1986) 2.01
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol (2000) 1.98
Neurologic aspects of inflammatory bowel disease. Neurology (1995) 1.90
Mesenteric panniculitis: review of the leterature and presentation of cases. Surgery (1977) 1.83
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol (2001) 1.69
Relationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients. Neurogastroenterol Motil (2006) 1.68
Self-expandable metal coil stents in the treatment of benign esophageal strictures refractory to conventional therapy: a case series. Gastrointest Endosc (2000) 1.63
The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62
The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol (1999) 1.61
Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am J Gastroenterol (2000) 1.59
Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer. Am J Obstet Gynecol (1996) 1.59
Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol (2000) 1.52
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer (2004) 1.41
Seasonal variations in the frequency of endoscopically diagnosed duodenal ulcer in Israel. J Clin Gastroenterol (1988) 1.41
Pulmonary aspergillosis in a child with hyperimmunoglobulin E syndrome. Clin Infect Dis (1998) 1.41
Seasonal fluctuations in acute upper gastrointestinal bleeding: lack of effect of nonsteroidal anti-inflammatory drugs. Am J Gastroenterol (1992) 1.39
Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis (1995) 1.34
Linkage of Niemann-Pick disease type C to human chromosome 18. Proc Natl Acad Sci U S A (1993) 1.33
Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes. Am J Hum Genet (1999) 1.32
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer (2001) 1.27
Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci U S A (1998) 1.26
Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24
Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol (2002) 1.21
Progesterone blocks cholesterol translocation from lysosomes. J Biol Chem (1992) 1.20
The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet (1999) 1.19
Eosinophilic cystitis in a 4-year-old boy: successful long-term treatment with cyclosporin A. Pediatrics (2001) 1.18
Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril (1996) 1.16
Serum complement after orthotopic transplantation of the human liver. Clin Exp Immunol (1972) 1.12
The Niemann-Pick C lesion and its relationship to the intracellular distribution and utilization of LDL cholesterol. Biochim Biophys Acta (1994) 1.12
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer (2006) 1.12
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. Dev Neurosci (1991) 1.08
Tumor suppressor p53 regulates heparanase gene expression. Oncogene (2006) 1.07
Detection of Australia antigen by biological assay in 'Au negative' kidney homograft recipients with hepatic dysfunction. Clin Exp Immunol (1972) 1.06
Complicated endoscopic pediatric procedures using deep sedation and general anesthesia are safe in the endoscopy suite. Scand J Gastroenterol (2004) 1.06
Preimplantation genetic diagnosis for BRCA1/2--a novel clinical experience. Prenat Diagn (2009) 1.05
Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. J Mammary Gland Biol Neoplasia (2001) 1.04
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer (1991) 1.02
Duodenal duplication cyst manifested by duodeno-jejunal intussusception and hyperbilirubinemia. J Pediatr Surg (1999) 1.02
Gallstone pancreatitis. Exploration of the biliary system in acute and recurrent pancreatitis. Arch Surg (1976) 1.02
Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma. J Skin Cancer (2013) 1.02
Niemann-Pick type-C disease: deficient intracellular transport of exogenously derived cholesterol. Am J Med Genet (1992) 1.01
Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients. Arch Surg (1990) 1.00
Topical capsaicin--a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut (2003) 1.00
Clinical diagnosis of secondary tumors of the heart and pericardium. Dis Chest (1969) 1.00
Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther (2010) 0.99
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
Splenic hematoma. A rare complication of colonoscopy. Surg Endosc (1998) 0.98
Type C Niemann-Pick disease: cellular uncoupling of cholesterol homeostasis is linked to the severity of disruption in the intracellular transport of exogenously derived cholesterol. Biochim Biophys Acta (1991) 0.97
Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer. Gastroenterology (1986) 0.97
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. Clin Oncol (R Coll Radiol) (2007) 0.96
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival. Br J Cancer (2007) 0.95
A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletion. Genes Chromosomes Cancer (2001) 0.95
Management of an inadvertently sutured nasogastric tube after Nissen fundoplication. Gastrointest Endosc (1994) 0.94
Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure. Gut (2001) 0.93
EsophaCoil: long-term results in 81 patients. Gastrointest Endosc (1998) 0.93
Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: a novel cause of achlorhydria and hypergastrinemia. Am J Surg Pathol (1999) 0.92
5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage. Oncology (1989) 0.92
Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy. J Clin Oncol (1990) 0.92
Therapeutic irradiation of the chest and electrocardiographic changes. Clin Radiol (1969) 0.91
The effect of music during warm-up on consecutive anaerobic performance in elite adolescent volleyball players. Int J Sports Med (2006) 0.91
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered (2001) 0.91
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma. Br J Cancer (2004) 0.91
Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients. Cancer Biomark (2012) 0.90
Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes. Am J Hum Genet (1998) 0.90
A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers. Oncology (1985) 0.90
Clinical studies of liposome-encapsulated doxorubicin. Acta Oncol (1994) 0.90
EZH2 promotes a bi-lineage identity in basal-like breast cancer cells. Oncogene (2013) 0.90
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br J Cancer (2002) 0.90
Treatment of chronic anal fissure with isosorbide dinitrate: long-term results and dose determination. Dis Colon Rectum (1998) 0.90
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel. Gynecol Oncol (2003) 0.90
Is there an interaction between BDKRB2 -9/+9 and GNB3 C825T polymorphisms and elite athletic performance? Scand J Med Sci Sports (2011) 0.89
Phosphorylation of a K+ channel alpha subunit modulates the inactivation conferred by a beta subunit. Involvement of cytoskeleton. J Biol Chem (1996) 0.89
Evidence for exercise-induced bone formation in premature infants. Int J Sports Med (2002) 0.89
[Solitary metastatic involvement of the spleen in squamous cell carcinoma of the cervix]. Harefuah (1977) 0.89
Plasma and tumor prolactin in colorectal cancer patients. Dig Dis Sci (1995) 0.89
Quantitative ultrasound measurements of bone speed of sound in premature infants. Eur J Pediatr (2001) 0.89
Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand J Gastroenterol (2002) 0.88
The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am J Hum Genet (1998) 0.88
Bone properties and muscle strength of young haemophilia patients. Haemophilia (2005) 0.88
The management of pericardial effusion in cancer patients. Chest (1977) 0.88
High-density lipoprotein and extracellular matrix promotes growth and plating efficiency of normal human mammary epithelial cells in serum-free medium. Int J Cancer (1983) 0.87
The mechanism of human bladder tumor implantation in an in vitro model. J Urol (1986) 0.87
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. Br J Cancer (2008) 0.87
Horner's syndrome: a complication of internal jugular vein cannulation. Infusionsther Klin Ernahr (1980) 0.87
Stress fractures of the medial malleolus--review of the literature and report of a 15-year-old elite gymnast. Foot Ankle Int (2002) 0.87
Genetic aspects of exercise and rhabdomyolysis. Pediatr Endocrinol Rev (2014) 0.87
Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig Dis Sci (1997) 0.86
The danger of high compliance balloons for esophageal dilatation in achalasia. Endoscopy (1990) 0.86
Effect of substance P on rat gastrointestinal transit. Dig Dis Sci (1988) 0.86
Transmission of response to trauma? Second-generation Holocaust survivors' reaction to cancer. Am J Psychiatry (2000) 0.86